On the afternoon of December 20, Canon has announced the completion of the acquisition process of Toshiba Medical Equipment's "Toshiba Medical System", with an acquisition of approximately 665.5 billion yen (at the current exchange rate, approximately RMB 39.5 billion. When the acquisition was announced in March) , about RMB 38.7 billion).
The above news was reported by Kyodo News Agency, a large Japanese news agency. Toshiba Medical Systems, a former Toshiba quality subsidiary, is principally engaged in the manufacture and sale of medical devices such as magnetic resonance imaging (MRI) and X-ray inspection instruments. In March of this year, Toshiba, which was exposed to a business crisis due to financial fraud, announced the sale of the subsidiary. After the acquisition of Fujifilm Holdings and other companies, Canon finally won.
In 2016, the fifth year of the fifth phase of the “Global Good Enterprise Group Concept†of Canon Group, Canon put forward the basic policy of “achieving strategic transformation and challenging new development†and formulated seven major strategies. The second article points out that diversification is achieved by expanding the peripheral business of existing businesses, and strives to create and expand new businesses. The management resources will be allocated to commercial printing, security surveillance cameras, life sciences and other fields, and the scale of business will be expanded as soon as possible through mergers and acquisitions.
Canon believes that the development of the medical field is huge, and it is developing CMOS sensors and inkjet printing technology to develop genetic testing devices that are greatly reduced in time. In 2015, Canon USA established Canon Biomedical Co., Ltd. with the goal of industrialization. In addition, it released the “Novallele†kit, which provides genetic sequence information for cancer and genetic disease research.
For the acquisition of Toshiba Medical Systems, Canon said that it will fully utilize Toshiba Medical's image diagnostic technology and other technologies to strengthen its medical business, and will also aim to explore new areas and explore further mergers and acquisitions.
Coral Fungus,Coral Mushroom,Coral Fungus Edible,Red Coral Fungus
Guangyun Agricultural Biotechnology (Jiangsu) Co., Ltd , https://www.7-mushrooms.com